Corporate Presentation
July 2014

Geron Analyst and Investor Meeting at ASH 2013
Presentation

 

2013 Annual Report
Download here

 
Webcast ImageWebcast
Q2 2014 Geron Earnings Conference Call (Live)
08/11/14 at 1:30 p.m. PT
Q2 2014 Geron Earnings Conference Call
Monday, August 11, 2014 1:30 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Recent NewsMore >>
DateTitle 
07/30/14Geron Announces Conference Call to Discuss Second Quarter 2014 Financial ResultsPrinter Friendly Version
06/12/14Geron Reports Removal of Partial Clinical Hold on Myelofibrosis ISTPrinter Friendly Version
05/28/14Geron to Present at the Jefferies Healthcare ConferencePrinter Friendly Version
Upcoming EventsMore >>
DateTitle
08/11/14
Q2 2014 Geron Earnings Conference Call
Stock Information
GERN (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$2.47
Change (%)0.00 (0.00%)
Volume2,290,243
Data as of 07/30/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
  
Contact Information

Anna Krassowska, Ph.D.
Tel: 650-473-7765
E-mail: investor@geron.com or media@geron.com



RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | Financial Tear Sheet Financial Tear Sheet
Close
Form content here please :)